As of November 6, 2025, Novo Nordisk and Eli Lilly have finalized deals with the US government to offer select GLP-1 obesity treatments at lower prices in exchange for broader Federal payer coverage, where Medicare patients will now be able to access injected obesity offerings for $50 per month
Upper gastrointestinal (GI) radiograph is useful to rule out other anatomical GI diseases, but it should not be considered an evaluation for reflux or reflux disease
Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients
For a plant-based option, whip up a quinoa salad with chickpeas and greens
After a thorough initial consultation, we will recommend a specific program and closely monitor you to ensure optimal results while maintaining safety
Using a semaglutide ratio on a retatrutide vial can deliver several times the intended dose